Jackson Kathy, MacLachlan Jennifer, Cowie Benjamin, Locarnini Stephen, Bowden Scott, Higgins Nasra, Karapanagiotidis Theo, Nicholson Suellen, Littlejohn Margaret
Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Department of Health and Human Services Victoria, Melbourne, Victoria, Australia.
Intern Med J. 2018 Nov;48(11):1308-1317. doi: 10.1111/imj.13967.
The incidence and trends of the hepatitis D virus (HDV) in Australia have not been recently assessed, and the circulating genotypes have never been determined.
To characterise the current virology and epidemiology of HDV.
Notifiable disease surveillance and laboratory testing data were analysed to assess demographics, risk factors and trends. HDV serology and RNA testing were performed on requested samples from 2010 to 2016. Sequencing of a 500-nucleotide amplicon of the delta antigen and phylogenetic analysis of the strains from 2009 to 2016 were also conducted.
Ninety HDV notifications were reported to the Victorian Department of Health and Human Services between 2010 and 2016. The majority (64.4%) of those diagnosed were born overseas, most commonly in Sudan, Pakistan and Vietnam. Over the same period, 190 patients tested positive for anti-HDV serology and 166 for HDV RNA. Sequencing of isolates from 169 individuals between 2009 and 2016 found that 80.5% strains were genotype 1, 16% genotype 5 and 3.5% genotype 2. Phylogenetic analysis confirmed the relatedness of strains from birth country, demonstrated the presence of the 'Pacific Island' genotype 1 strain in Queensland and supported possible transmission in correctional facilities and within families.
This study demonstrates the ongoing need for routine HDV screening and engagement in clinical care for people living with HBV in Australia. Epidemiological findings highlight the diversity in those affected and provide insights into local and global geographic distribution and transmission patterns.
澳大利亚丁型肝炎病毒(HDV)的发病率及趋势尚未得到近期评估,其流行基因型也从未被确定。
描述当前HDV的病毒学及流行病学特征。
分析法定传染病监测和实验室检测数据,以评估人口统计学、危险因素及趋势。对2010年至2016年送检样本进行HDV血清学和RNA检测。还对2009年至2016年毒株的δ抗原500个核苷酸扩增子进行测序及系统发育分析。
2010年至2016年期间,维多利亚州卫生与公众服务部共收到90例HDV报告。大多数确诊患者(64.4%)出生在海外,最常见于苏丹、巴基斯坦和越南。同一时期,190例患者抗-HDV血清学检测呈阳性,166例HDV RNA检测呈阳性。对2009年至2016年169例个体的分离株测序发现,80.5%的毒株为1型基因型,16%为5型基因型,3.5%为2型基因型。系统发育分析证实了来自出生国毒株的相关性,证明昆士兰州存在“太平洋岛屿”1型基因型毒株,并支持在惩教设施和家庭内部可能存在传播。
本研究表明,澳大利亚持续需要对HBV感染者进行常规HDV筛查并提供临床护理。流行病学研究结果突出了受影响人群的多样性,并为当地和全球地理分布及传播模式提供了见解。